Provided by Tiger Fintech (Singapore) Pte. Ltd.

IceCure Medical Ltd.

1.20
+0.02001.69%
Pre-market: 1.250.0600+5.04%06:01 EDT
Volume:170.69K
Turnover:205.99K
Market Cap:67.88M
PE:-3.99
High:1.23
Open:1.20
Low:1.17
Close:1.18
Loading ...

Company Profile

Company Name:
IceCure Medical Ltd.
Exchange:
NASDAQ
Establishment Date:
2006
Employees:
65
Office Location:
7 Ha’Eshel Street,PO Box 3163,Caesarea,Israel
Zip Code:
3079504
Fax:
972 4 623 0222
Introduction:
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Directors

Name
Position
Eyal Shamir
Chief Executive Officer, Director
Ron Mayron
Chairman of the Board
Doron Birger
Director
Oded Tamir
Director
Sharon Levita
Director
Yang Huang
Director

Shareholders

Name
Position
Eyal Shamir
Chief Executive Officer, Director
Ronen Tsimerman
Chief Financial Officer, Chief Operation Officer
Naum Muchnik
Vice President, Research, Development and Engineering
Shay Levav
Vice President, Regulatory and Quality Assurance and Clinical Applications
Tlalit Bussi Tel Tzure
Vice President, Business Development and Global Marketing